Navigation Links
Canadian firm buys Proventiv Therapeutics, makes ex-Bone Care exec CEO

Madison, Wis. - In a merging of complementary companies, Cytochroma, Inc., a Canadian firm seeking to commercialize new Vitamin D products, has acquired Proventiv Therapeutics, LLC, of Madison, and the combined company is looking for an additional $25 million in venture capital from Canadian and American investors.

Proventiv was founded in Se......

Full article >>> are employee Keith H. Crawford, who will be vice president of strategic planning for Cytochroma.

Jay A. White, the new vice president of product development, is the former vice president of operations at Cytochroma.

Continuing in their present roles will be Martin Petkovich, chief scientific officer, and Jukka K. Karjalainen, vice president of clinical affairs.

Rae, Cyt......

Full article >>> F's goals," Block said in a statement.

......

Full article >>>
'"/>

Source:wistechnology.com By Joe Vanden Plas 06/29/06


Related biology technology :

1. GE Healthcare enters agreement with Canadian health authority
2. Canadian firm acquires Silicon Logic
3. Take off: Canadian biotech industry thrives
4. Merge eFilm corporate merger with Canadian firm moves ahead
5. Standard Imaging acquires Canadian PIPSpro radiation treatment technologies
6. Standard Imaging acquires Canadian PIPSpro radiation treatment technologies
7. EraGen signs Canadian Market Distribution Agreement for nucleic acid dection products
8. BIO 2007: Wisconsin makes its presence felt
9. Tired of the spin? ExpertVoter website makes candidate selection easier
10. Whitewater makes plans for business incubator
11. Online service makes board connections
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/12/2017)... The report "Direct-Fed Microbials Market by Type (Lactic Acid Bacteria and Bacillus), Livestock (Pork/Swine, Poultry, ... to 2022", published by MarketsandMarkets, the global market is estimated to be valued ... by 2022, at a CAGR of 6.96% from 2016. ... ... ...
(Date:1/11/2017)... , ... January 11, 2017 , ... ... Clinical Cancer Research show early promise of the investigational anti-cancer agent tucatinib (formerly ... median 5 previous treatment regimens. Twenty-seven percent of these heavily pretreated patients saw ...
(Date:1/11/2017)... ... January 11, 2017 , ... ... clinics in Peru studying the pathogens that cause malaria and tuberculosis. Seeing firsthand ... path of discovery. , Now, as an assistant professor of biology and biotechnology ...
(Date:1/11/2017)... , Jan. 11, 2017  Brian Mehling, M.D., world-renowned ... of Blue Horizon International (BHI), will be attending the ... Davos from January 17-20, 2017. This will ... The theme of this year,s forum is ... 400 sessions will address strategies for fostering greater social ...
Breaking Biology Technology:
(Date:12/15/2016)... Canada and BADEN-BADEN, Germany , ... a leading global financial services provider, today announced an agreement ... passive behavioural biometrics, to join forces. The partnership will enable ... mitigation strategies in compliance with local data protection regulation. ... In order ...
(Date:12/15/2016)... , Dec. 15, 2016  There is much more ... or starting the engine. Continental will demonstrate the intelligence ... Las Vegas . Through the combination of the ... Entry) and biometric elements, the international technology company is ... personalization and authentication. "The integration of biometric ...
(Date:12/8/2016)... , Dec. 8, 2016  Singulex, Inc., the leader ... technology, entered into a license and supply agreement with ... The agreement provides Singulex access to Thermo Scientific BRAHMS ... is used to diagnose systemic bacterial infection ... to aid in assessing the risk of ...
Breaking Biology News(10 mins):